According to reports, Belanger is a believer in Ocular mainly on the potential of its investigational Axpaxli, a drug that ...

The Nasdaq Composite index has entered correction territory as the tech-laden market index is now down more than 13% from the ...

The semiconductor industry has been the center of attention for investors looking to get into the United States technology ...